Lexicon Pharmaceuticals LXRX Treasury Stock
Treasury Stock at other companies
Other financials
Where this comes from
Reported directly by Lexicon Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:TreasuryStockValue.
The official record: Lexicon Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Lexicon Pharmaceuticals's treasury stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Lexicon Pharmaceuticals's treasury stock?
- Lexicon Pharmaceuticals (LXRX) reported treasury stock of $2.84M in Q1 2026.
- How has Lexicon Pharmaceuticals's treasury stock changed year-over-year?
- Lexicon Pharmaceuticals's treasury stock decreased by 45.2% year-over-year, from $5.19M to $2.84M.
- What is the long-term trend for Lexicon Pharmaceuticals's treasury stock?
- Over 5 years (2020 to 2025), Lexicon Pharmaceuticals's treasury stock has grown at a 1.4% compound annual growth rate (CAGR), from $4.84M to $5.19M.
- What does treasury stock mean?
- Shares repurchased by the company and held in treasury, reducing equity. Recorded at cost and presented as a negative equity component.